Latest News

Date Title Topic
17 Dec 2015 ESMO Asia 2015 Press Release: Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer Head and neck cancers - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
17 Dec 2015 ESMO Asia 2015 Press Release: Cancer drives patients to poverty in Southeast Asia Bioethics, legal and economic issues
16 Dec 2015 No Benefit From Adjuvant Chemotherapy in High Risk Premenopausal Luminal A Breast Cancer Patients Breast cancer - Pathology/Molecular biology - Anticancer agents & Biologic therapy
16 Dec 2015 The Impact of Adjuvant Denosumab on Disease-free Survival in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer Breast cancer - Palliative and supportive care - Anticancer agents & Biologic therapy
16 Dec 2015 MEDIA ALERT: ESMO Asia 2015 Congress Preview
15 Dec 2015 FDA Approves Uridine Triacetate for the Emergency Treatment of Patients Who Receive an Overdose of Fluorouracil or Capecitabine Palliative and supportive care
14 Dec 2015 FDA Approves Alectinib for the Treatment of Advanced ALK-positive NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
10 Dec 2015 New Treatments in Melanoma
10 Dec 2015 Limited offer: Free submission for ESMO Open
10 Dec 2015 FDA Allows Marketing of Cooling Cap to Reduce Alopecia During Chemotherapy Palliative and supportive care
09 Dec 2015 Midostaurin Prolongs Survival in Newly Diagnosed Acute Myeloid Leukaemia Patients With FLT3 Mutations Haematologic malignancies - Anticancer agents & Biologic therapy
07 Dec 2015 PD-1 Blockade Sets a New Benchmark in Previously Treated Metastatic Renal Cell Carcinoma (mRCC) Genitourinary cancers
General Assembly